Cincinnati--One in four Americans will suffer from a serious mental
health disorder in their lifetime, according to the National Institute
of Mental Health. The high prevalence rate of mental illness has led
the University of Cincinnati Department of Psychiatry to create a new
research program called The Cincinnati Neuroscience (CNS) Group.
mission of the CNS Group is to conduct research contributing to
scientific advances in the understanding and treatment of mental
"Clinical treatment trials are crucial to improving the
treatment of medical and mental illnesses," said Paul Keck, MD,
professor and vice chair for research. "The CNS Group is adding to one
of the leading research departments of psychiatry in the country."
CNS Group consists of two closely related research programs, the
Biological Psychiatry Program and the Women's Health Research Program.
Biological Psychiatry Program conducts research regarding the
biological causes and treatments for mood (bipolar and major depressive
disorders), psychotic (schizophrenia, schizoaffective disorder), eating
(obesity, binge eating, bulimia nervosa) and impulse control disorders
(pathological gambling, intermittent explosive disorder).
program is a site of the Stanley Foundation Bipolar Network, the
largest and most comprehensive research program dedicated to the
development of new medications for people with bipolar disorder. It is
comprised of a group of internationally renown researchers who are
investigating the long-term course of biploar disorder to develop
better treatment strategies for managing the illness. The UC site is
one of just five research field centers throughout the world.
Women's Health Research Program is dedicated to improving
theunderstanding and treatment of health problems that are of
particular concern to womensuch as postpartum mood disorders,
fibromyalgia and depression. The program is also researching sexual
dysfunction, premenstrual and menopausal depression, chronic fatigue
syndrome, irritable bowel syndrome and migraine headaches.
are many advantages to participating in one of these clinical trials,"
Keck said. "Participants have the chance to receive an evaluation by
multiple medical practitioners who are experts in their fields. They
get free study-related medications, visits or tests and follow up
treatment. In addition, they have the knowledge that they are advancing
scientific knowledge about medical treatment."
conducting the clinical trials are Keck; Susan McElroy, MD professor of
psychiatry; Lesley Arnold, MD, associate professor of psychiatry and
director of the Women's Health Research Program; Erik Nelson, MD,
assistant professor of psychiatry and Shishuka Malhotra, MD.
For more information about the CNS Group and the current clinical trials being conducted, please call 558-UCNS.